Scholars Central

Review articlePublished 26 Jul 2016

Novel mechanisms and new therapies for chronic obstructive pulmonary disease

Authors: Peter J Barnes

Clinical Practice

Volume 6 · Issue 6 · Pages 795

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

There is a pressing requirement to develop new therapies for chronic obstructive pulmonary disease (COPD), as current therapies fail to prevent disease progression or mortality and do not deal with the underlying inflammatory process. The mainstay of current drug therapy is long-acting bronchodilators, but no treatments suppress chronic inflammation in COPD, which is corticosteroid-resistant. With better understanding of the inflammatory and destructive process in the pathophysiology of COPD, several novel therapeutic targets have been identified, leading to the development of various mediator antagonists, novel broad-spectrum anti-inflammatory treatments and drugs that may reverse the molecular mechanisms of corticosteroid resistance.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Clinical Practice.

All its articles

Article · 28 Mar 2025

Using

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalClinical Practice
  • SubjectGeneral & Internal Medicine
  • BylineArticles whose byline prints “Peter J Barnes”